| human | Q5 |
| P269 | IdRef ID | 061626430 |
| P213 | ISNI | 0000000139473591 |
| P496 | ORCID iD | 0000-0001-7006-4462 |
| P3829 | Publons author ID | 2187550 |
| P1053 | ResearcherID | R-1129-2016 |
| P214 | VIAF ID | 211081435 |
| P185 | doctoral student | Florence Bretelle | Q38641788 |
| Valery Combes | Q42712814 | ||
| Laurence Camoin-Jau | Q92092611 | ||
| P69 | educated at | Aix-Marseille University | Q2302586 |
| P108 | employer | Aix-Marseille University | Q2302586 |
| P735 | given name | Françoise | Q1244936 |
| Françoise | Q1244936 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q38297898 | A hierarchical analysis of transcriptome alterations in intrauterine growth restriction (IUGR) reveals common pathophysiological pathways in mammals |
| Q90403197 | A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance |
| Q100514180 | A new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids |
| Q49248438 | A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule |
| Q51793650 | A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity. |
| Q47372337 | A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants |
| Q46490499 | A threshold of platelet reactivity for ischaemic events? |
| Q52983005 | ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors' Angiogenic Potential and Homing Ability. |
| Q34403678 | Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression |
| Q33443707 | Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains |
| Q57039912 | Activation of Human Endothelial Cells via S-Endo-1 Antigen (CD146) Stimulates the Tyrosine Phosphorylation of Focal Adhesion Kinase p125FAK |
| Q40112496 | Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro |
| Q91325633 | Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro |
| Q46665436 | Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study |
| Q47233830 | Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors. |
| Q57039762 | Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation |
| Q36113914 | Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies |
| Q46982848 | Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization |
| Q86444510 | Antiplatelet properties of oral anticoagulants |
| Q45360139 | Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. |
| Q49666836 | Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome. |
| Q53718855 | Arginase up-regulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction. |
| Q50209119 | Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease. |
| Q50469571 | Assessment of organ culture for the conservation of human skin allografts. |
| Q47970239 | Autologous adipose-derived stromal vascular fraction in patients with systemic sclerosis: 12-month follow-up |
| Q60947259 | Avancées dans la physiopathologie de la pré-éclampsie : place de la réponse inflammatoire |
| Q41422353 | Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6. |
| Q84969244 | Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot study |
| Q83996748 | Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction |
| Q62606133 | C0082 Circulating leukocyte- and endothelial-derived microparticles support a fibrinolytic activity |
| Q91878055 | CD146 (Cluster of Differentiation 146) |
| Q28235736 | CD146 and its soluble form regulate monocyte transendothelial migration |
| Q92717753 | CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment |
| Q51030489 | CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation. |
| Q62606125 | CD146 mediates VEGF-induced permeability and promotes melanoma metastasis in vivo |
| Q43071449 | CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo. |
| Q46745585 | CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells |
| Q104476649 | CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases |
| Q61643638 | CD146: biosynthesis and production of a soluble form in human cultured endothelial cells |
| Q85665649 | COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study |
| Q37331535 | Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. |
| Q87921419 | Cancer risk in HIV-infected patients: elite controllers are also concerned |
| Q44922821 | Cell adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glucocorticoids |
| Q83817833 | Centrifugation is a crucial step impacting microparticle measurement |
| Q45911927 | Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment. |
| Q50474036 | Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. |
| Q84227858 | Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions |
| Q74464704 | Cholesterol and omega-3 fatty acids inhibit Na, K-ATPase activity in human endothelial cells |
| Q90739200 | Circadian Rhythm Disruption and Sepsis in Severe Trauma Patients |
| Q57767355 | Circulating Endothelial Cells |
| Q98565027 | Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 |
| Q80557646 | Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes |
| Q33416860 | Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study. |
| Q34079981 | Circulating endothelial cells in vascular disorders: new insights into an old concept |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q81402646 | Circulating endothelial cells. Biomarker of vascular disease |
| Q36030562 | Circulating endothelial cells: realities and promises in vascular disorders |
| Q82461878 | Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque |
| Q51692038 | Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica. |
| Q80722701 | Circulating microparticles in renal diseases |
| Q60621577 | Circulating microparticles may influence early carotid artery remodeling |
| Q42937873 | Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism |
| Q94545021 | Commentary about mesenchymal stem cells and scarred vocal folds |
| Q80565325 | Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions |
| Q53480416 | Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes. |
| Q61853594 | Cutaneous thrombotic and necrotizing microangiopathy revealing a large granular lymphocytic leukaemia |
| Q70169676 | Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody |
| Q36772138 | Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions. |
| Q82462357 | Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry |
| Q79750587 | Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay? |
| Q84502058 | Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay |
| Q100312865 | Development and Validation of a Fully GMP-Compliant Process for Manufacturing Stromal Vascular Fraction: A Cost-Effective Alternative to Automated Methods |
| Q40729443 | Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads |
| Q77402442 | Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals |
| Q80747597 | Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis? |
| Q37892318 | Does uremia cause vascular dysfunction? |
| Q33490903 | Early postnatal overfeeding induces early chronic renal dysfunction in adult male rats |
| Q59138135 | Early prediction of revascularisation by angiomotin-targeting positron emission tomography |
| Q47180135 | Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes. |
| Q42449353 | Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin |
| Q88497141 | Effects of platelets on cancer progression |
| Q46888760 | Elevation of circulating endothelial microparticles in patients with chronic renal failure. |
| Q37386464 | Emergence of the concept of platelet reactivity monitoring of response to thienopyridines |
| Q33722081 | Endothelial Progenitors: A Consensus Statement on Nomenclature |
| Q39817958 | Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases |
| Q52773759 | Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches. |
| Q83321296 | Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease |
| Q37319478 | Endothelial microparticles in diseases |
| Q79826484 | Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome |
| Q51806272 | Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. |
| Q33578948 | Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers |
| Q33417775 | Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases |
| Q48446597 | Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study. |
| Q74422828 | Evidence that human endothelial cells express different isoforms of Na,K-ATPase |
| Q33333234 | Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney |
| Q33663907 | Extracellular Vesicles in Angiogenesis. |
| Q91936638 | Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation |
| Q64891460 | FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant. |
| Q60946551 | Factor VIII:C levels in pregnancies complicated by pre-eclampsia and intrauterine growth restriction |
| Q83346533 | Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade |
| Q89693640 | Feasibility of First Injection of Autologous Adipose Tissue-Derived Stromal Vascular Fraction in Human Scarred Vocal Folds: A Nonrandomized Controlled Trial |
| Q47135651 | Fibrin-bearing microparticles: marker of thrombo-embolic events in pancreatic and colorectal cancers |
| Q33959551 | Fibrinolytic cross-talk: a new mechanism for plasmin formation. |
| Q43744046 | Forearm ischemia decreases endothelial colony-forming cell angiogenic potential |
| Q36574499 | Formulation and storage of platelet-rich plasma homemade product |
| Q34062549 | Fractalkine expression induces endothelial progenitor cell lysis by natural killer cells |
| Q50579795 | Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer. |
| Q50220305 | Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy |
| Q42696297 | Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors |
| Q45364186 | Hepatitis E virus infection in patients infected with the human immunodeficiency virus |
| Q81225760 | Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results |
| Q35567262 | High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome |
| Q84582096 | High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes |
| Q83120357 | High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors |
| Q47326811 | High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report |
| Q39707911 | Histological and Urodynamic Effects of Autologous Stromal Vascular Fraction Extracted from Fat Tissue with Minimal Ex Vivo Manipulation in a Porcine Model of Intrinsic Sphincter Deficiency |
| Q43269924 | Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism |
| Q44788173 | Homocysteine modulates the proteolytic potential of human vascular endothelial cells |
| Q52544714 | Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. |
| Q88295641 | Identification of CD146 as a novel molecular actor involved in systemic sclerosis |
| Q60946424 | Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development |
| Q41240287 | Identification of the S-Endo 1 endothelial-associated antigen |
| Q44110299 | Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma |
| Q41078081 | Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules |
| Q43242016 | Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients |
| Q40658695 | Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. |
| Q73664161 | Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients |
| Q46313514 | Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
| Q46026792 | Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. |
| Q84521307 | Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children |
| Q59806401 | Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis |
| Q46254973 | Improved biological efficacy of prasugrel one month after an acute coronary syndrome |
| Q40851071 | In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. |
| Q43910021 | Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease |
| Q59607694 | Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: Relationship with oxidative stress |
| Q48685382 | Increased mean corpuscular haemoglobin concentration: artefact or pathological condition? |
| Q37713525 | Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis |
| Q92870939 | Increasing the sensitivity of the human microvesicle tissue factor activity assay |
| Q44141875 | Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway |
| Q48150663 | Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling |
| Q51730485 | Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. |
| Q40732139 | Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity |
| Q42952510 | Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy |
| Q92420527 | Involvement of Platelets in Cancers |
| Q38184163 | Involvement of neutrophils in thrombus formation in living mice |
| Q38229393 | Involvement of platelet-derived microparticles in tumor progression and thrombosis |
| Q46929685 | Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. |
| Q83426472 | Kidney transplantation decreases the level and procoagulant activity of circulating microparticles |
| Q43694208 | Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years |
| Q41617888 | Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma |
| Q57039590 | Les cellules natural killer : acquisitions récentes et implication en pathologie humaine |
| Q33401969 | Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis |
| Q42905599 | Level of adenosine diphosphate receptor P2Y12 blockade during percutaneous coronary intervention predicts the extent of endothelial injury, assessed by circulating endothelial cell measurement. |
| Q44439536 | Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients |
| Q48033090 | Long-Term Recovery After Endothelial Colony-Forming Cells or Human Umbilical Cord Blood Cells Administration in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy. |
| Q38878106 | Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients. |
| Q45752413 | Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient |
| Q37759939 | Low birth weight infants and the developmental programming of hypertension: a focus on vascular factors. |
| Q44514184 | Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children |
| Q90013734 | MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments |
| Q41811602 | Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect |
| Q60947513 | Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia |
| Q97871042 | Mathematical modeling of peripheral blood neutrophil kinetics to predict CLAD after lung transplantation |
| Q82750280 | Measurement of platelet microparticles |
| Q62977671 | Measuring circulating cell-derived microparticles |
| Q57461344 | Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells |
| Q39299869 | Methodological Guidelines to Study Extracellular Vesicles |
| Q39030810 | Microparticles and Fibrinolysis |
| Q38805409 | Microparticles and cancer thrombosis in animal models. |
| Q37994379 | Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation |
| Q37240175 | Microparticles in vascular diseases |
| Q60621576 | Microparticles: An Introduction |
| Q38072878 | Microparticles: new protagonists in pericellular and intravascular proteolysis |
| Q92730036 | Microvesicles and Cancer Associated Thrombosis |
| Q50205919 | Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology |
| Q54496757 | Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization. |
| Q47268971 | Mobilization of CD34+KDR+ endothelial progenitor cells predicts target lesion revascularization: a reply to a rebuttal concerning power and sample size calculation. |
| Q24678755 | Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin |
| Q44261411 | Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231. |
| Q90905176 | Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis |
| Q71097102 | Monoblastic leukemia in an HIV-infected patient: absence of viral expression in RNA blasts |
| Q81479322 | More on: Measuring circulating cell-derived microparticles |
| Q56573171 | More on: calibration for the measurement of microparticles: value of calibrated polystyrene beads for flow cytometry-based sizing of biological microparticles |
| Q57039476 | Mouse CD146/MCAM is a marker of natural killer cell maturation |
| Q103825301 | Multifaceted role of extracellular vesicles in atherosclerosis |
| Q90726018 | Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release |
| Q79923438 | Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients |
| Q60947615 | Neutrophil activation in preeclampsia and isolated intrauterine growth restriction |
| Q92727519 | Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus |
| Q35113822 | Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin. |
| Q43842966 | New developments of antiplatelet drugs |
| Q63915154 | New horizons in vascular biology and thrombosis: Highlights from EMVBM 2009 |
| Q53370781 | Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome. |
| Q33921887 | Outside-in signaling pathway linked to CD146 engagement in human endothelial cells |
| Q37806990 | Overcoming limitations of microparticle measurement by flow cytometry |
| Q80234462 | P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro |
| Q35230316 | P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice |
| Q51563625 | Personalized Antiplatelet Therapy: The Odyssey Continues. |
| Q37592880 | Physico-chemical factors influencing autologous conditioned serum purification. |
| Q62606094 | Plasmatic Level of Leukocyte-Derived Microparticles Is Associated With Unstable Plaque in Asymptomatic Patients With High-Grade Carotid Stenosis |
| Q53411184 | Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients. |
| Q51835782 | Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode. |
| Q44104062 | Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention. |
| Q38437993 | Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention. |
| Q82863142 | Platelets and endothelium: two key players in percutaneous coronary intervention |
| Q92650591 | Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy |
| Q38876413 | Pleiotropic effects of ticagrelor: Myth or reality? |
| Q38437197 | Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes |
| Q39132672 | Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment |
| Q44401873 | Premature birth is associated with not fully differentiated contractile smooth muscle cells in human umbilical artery |
| Q82256218 | Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells |
| Q54501461 | Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential. |
| Q36600785 | Procoagulant microparticles: disrupting the vascular homeostasis equation? |
| Q38626228 | Production of platelet-rich plasma gel from elderly patients under antithrombotic drugs: Perspectives in chronic wounds care |
| Q40779188 | Profile of endothelial and leukocyte activation in Fabry patients |
| Q60947112 | Protein Z in patients with pregnancy complications |
| Q37587272 | Protein-bound toxins--update 2009. |
| Q52194007 | Quantitative analysis of leukocyte membrane antigen expression on human fetal and cord blood: normal values and changes during development. |
| Q51008605 | Quantitative analysis of leukocyte membrane antigen expression: normal adult values. |
| Q90750201 | Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction |
| Q46046079 | Rate of nuisance bleedings and impact on compliance to prasugrel in acute coronary syndromes |
| Q43236938 | Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention |
| Q43174983 | Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention |
| Q84729330 | Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel |
| Q87448514 | Reply: Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice |
| Q98725319 | Response to Universal Classification System for Platelet-Rich Plasma (PRP): A Method to define the variables in PRP production |
| Q91759543 | Response to: 'Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al' by De Benedetto et al |
| Q92985599 | Response to: 'Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?' by Manetti |
| Q57265423 | Restoration of soluble CD146 in patients with Crohnʼs disease treated with the TNF-α antagonist infliximab |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q73292617 | Rickettsia conorii infection enhances vascular cell adhesion molecule-1- and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells |
| Q38750593 | Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. |
| Q45304530 | Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome |
| Q62606141 | Rôle des microparticules cellulaires à l’interface des réponses prothrombotiques et inflammatoires |
| Q71956668 | S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen |
| Q90776878 | Sepsis is associated with lack of monocyte HLA-DR expression recovery without modulating T-cell reconstitution after lung transplantation |
| Q97545265 | Sera From Patients With Minimal Change Disease Increase Endothelial Permeability to Sodium |
| Q56908370 | Serum erythropoietin and reticulocyte maturity index after renal transplantation: a prospective longitudinal study |
| Q83567191 | Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles |
| Q52144823 | Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats. |
| Q84227557 | Soluble CD146 and APS: a potential biomarker of obstetrical complications? |
| Q52870031 | Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform. |
| Q83038813 | Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia |
| Q55259270 | Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma. |
| Q33194539 | Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration |
| Q36307573 | Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization |
| Q60609022 | Soluble MHC Class I chain-related molecule serum levels are predictive markers of implantation failure and successful term pregnancies following IVF |
| Q34326616 | Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin |
| Q53571554 | Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity. |
| Q48789227 | Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. |
| Q47254315 | Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? |
| Q53168104 | Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. |
| Q39590400 | Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. |
| Q39008328 | Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter? |
| Q55437132 | Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy. |
| Q35651080 | Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α |
| Q77900935 | Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies |
| Q51782206 | TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. |
| Q42596148 | Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. |
| Q46187200 | Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis |
| Q40534218 | Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors. |
| Q101405562 | Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine |
| Q50942203 | The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study. |
| Q91285514 | The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis |
| Q35228517 | The cardiovascular effect of the uremic solute indole-3 acetic acid |
| Q38319415 | The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. |
| Q37821169 | The many faces of endothelial microparticles. |
| Q86075243 | The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study |
| Q74318842 | The platelet and endothelium in HIV infection |
| Q80085620 | The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells |
| Q40235409 | The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. |
| Q90241556 | Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors |
| Q44045737 | Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats. |
| Q89542091 | Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors |
| Q40276225 | Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. |
| Q92853004 | Thrombosis Risk Associated with Head and Neck Cancer: A Review |
| Q28300388 | Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties |
| Q46539901 | Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes. |
| Q43492564 | Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level. |
| Q91945913 | Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel |
| Q43873602 | Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. |
| Q87061829 | Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study |
| Q54704923 | Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study. |
| Q54424430 | Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro. |
| Q34353655 | Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation |
| Q92974446 | Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity |
| Q48175406 | Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke |
| Q81386213 | Tubular CD146 expression in nephropathies is related to chronic renal failure |
| Q46841145 | Two strategies of clopidogrel loading dose to decrease the frequency of clopidogrel resistance in patients undergoing percutaneous coronary intervention |
| Q44114915 | Type 1 and type 2 diabetic patients display different patterns of cellular microparticles |
| Q42440968 | Unexplained pregnancy loss: a marker of basal endothelial dysfunction? |
| Q33377463 | Update on thrombotic thrombocytopenic purpura |
| Q96302372 | Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction |
| Q59333310 | Use of platelet-rich plasma in regenerative medicine: technical tools for correct quality control |
| Q37891155 | Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction. |
| Q53554561 | Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. |
| Q33296436 | WISE 2005: chronic bed rest impairs microcirculatory endothelium in women |
| Q79106709 | [Activation of adhesion molecules in patients with septic shock] |
| Q84392455 | [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence] |
| Q82339391 | [Soluble CD146: a new angiogenic molecule involved in physiopathology] |
Search more.